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a  b  s  t  r  a  c  t
Cigarette  smoke  (CS) is a major  risk  factor  for emphysematous  changes  in the lungs  and  the
underlying  mechanism  involves  CS-induced  cell  death.  In  the  present  study  we  investigated
the  ability  of  nutrients  to rescue  CS-induced  cell death.  We observed  that  pre-treatment
with  excess  leucine  can  partially  rescue  CS  extract-induced  cell  death  in  Saccharomyces
cerevisiae  and alveolar  epithelial  A549  cells.  Excess  dietary  leucine  was  also  effective  in
alleviating  effects  of  CS  in guinea  pig  lungs.  Further  investigation  to understand  the  under-
lying mechanism  showed  that  CS  exposure  causes  downregulation  of  leucine  transporter
that results  in inactivation  of mTOR,  which  is  a positive  regulator  of  protein  synthesis  andEmphysema
Cigarette smoke
Leucine
LAT1
mTOR
cell proliferation.  Notably,  leucine  supplemented  diet  ameliorated  even  existing  CS-induced
emphysematous  changes  in guinea  pig lung,  a  condition  hitherto  thought  to  be  irreversible.
Thus  the  current  study  documents  a new  mechanism  by  which  CS  affects cellular  physiology
wherein  leucine  transporter  is a key target.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
Y-NC-Nthe CC  BAbbreviations: CS, cigarette smoke; CSE, cigarette smoke extract; ROS,
reactive oxygen species; mTOR, mammalian target of rapamycin; H & E,
hematoxylin and eosin; ChIP, chromatin immune precipitation; Mad1,
Max  dimerization protein 1; Lat1, L-type amino acid transporter 1; YCM,
yeast complete media; Bap2, branched-chain amino acid permease; Tat1,
tyrosine and tryptophan amino acid transporter 1; PCR, polymerase chain
reaction; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end
labeling; EtBr, ethidium bromide; V, valine; L, leucine; I, isoleucine; S,
serine; K, lysine; Y, tyrosine; W,  tryptophan; T, threonine; F, phenylala-
nine; H, histidine; M,  methionine; R, argnine; N, asparagine; E, glutamic
acid.
∗ Corresponding author. Tel.: +91 9831836050.
E-mail address: alokksil7@gmail.com (A.K. Sil).
http://dx.doi.org/10.1016/j.toxrep.2014.09.011
2214-7500/© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open
org/licenses/by-nc-nd/3.0/).D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Emphysema, a major cause of morbidity and mortality,
is a type of inﬂammatory disease deﬁned by abnormal and
permanent enlargement of the airspaces of alveolar cells.
A  primary risk factor for this disease is cigarette smok-
ing  [1,2]. An underlying reason for the harmful nature of
cigarette  smoke (CS) is that it is a very rich source of oxi-
dants.  It contains more than 1015 free radicals and ∼4700
reactive chemical compounds [3]. In addition, CS induces
the  generation of reactive oxygen species (ROS) within
cells, which cause oxidative stress [4]. Oxidative stress
in  turn leads to inﬂammation and the resulting apopto-
sis  contributes to alveolar epithelial cell loss leading to
emphysema [4,5]. Consistently, studies have documented
the presence of apoptotic cells in the lungs of emphysema
 access article under the CC BY-NC-ND license (http://creativecommons.
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atients [5,6]. In addition to apoptosis, a number of studies
lso  document autophagic cell death in the lungs of both
mphysema patients and mouse exposed to CS [7,8]. The
rocess  of autophagy is highly regulated and nutritional
eprivation is one of the major signals for its induction
9,10]. Thus CS-induced cell death is a complex process that
nvolves  multiple pathways and the underlying regulatory
echanisms are yet to be fully understood.
There is a relationship between stress response and
utritional status as better nutrient availability has been
hown  to combat the effects of stress [11]. Therefore, the
urrent  study investigated whether nutrient availability
odulates cellular response to CS. Using both in vitro and
n  vivo approaches, we  present evidence that increased
vailability of leucine, an essential amino acid, provides
rotection against CS-induced cell death. We  have also
hown  that CS exposure causes downregulation of LAT1, a
biquitously  expressed gene encoding a high afﬁnity per-
ease  for branched chain amino acids like leucine [12].
dditionally, ectopic expression of the Lat1 protein could
artially prevent the CS-induced cell death. This protective
unction of leucine and Lat1 is mediated by mammalian
arget of rapamycin (mTOR), which is a Ser/Thr kinase
hat plays a crucial role in cell growth and proliferation
y globally regulating transcription and translation [13].
nterestingly we also observed that dietary leucine sup-
lement reverses pre-existing emphysematous changes of
uinea  pig lung.
.  Materials and methods
.1.  Preparation of cigarette smoke extracts (CSE)
CSE was prepared using a commercially available ﬁlter-
ipped cigarette with a tar content of 15 mg  and nicotine
ontent of 1 mg  manufactured by the Indian Tobacco Com-
any  Limited (ITC Ltd.) as described previously [14,15]. The
moke  from a cigarette was bubbled through 1 ml  of 50 mM
BS,  pH 7.4, till the cigarette was consumed completely. The
H  of this aqueous CSE was adjusted to 7.4 using NaOH and
as  ﬁlter sterilized by passing the extract through 0.2 m
yringe  ﬁlter. Different batches of CSE preparations were
ormalized by measuring their absorbance at 270 nm.  The
D270 of 0.6 was considered as 100% CSE. This 100% stock
olution was diluted to 3% or 20% as per the requirement
f the experiment.
.2.  Yeast strain, media, CSE treatment
Saccharomyces cerevisiae strain 301-2B (MAT  leu2-
,112 ura3-52 his434 trp) [16] was used and unless
entioned, yeast cells were grown in standard synthetic
omplete medium (YCM) that contains 2% glucose and
.1%  amino acid mixture (containing arginine – 0.9 g,
ethionine – 0.9 g, tyrosine – 1.35 g, isoleucine – 1.35 g,
henylalanine – 1.35 g, aspartic acid – 4.5 g, glutamic acid
 4.5 g, valine – 4.5 g, threonine – 4.5 g and serine – 4.5 g)
long with 0.01% leucine and 0.005% lysine.
Exponentially growing S. cerevisiae cells were treated
ith different doses of CSE for different time periods. Cells
ere  grown in YCM supplemented with either excess ofrts 1 (2014) 752–763 753
glucose  or excess amino acids followed by CSE treatment
and spotted on YCM plates.
Gene  knockout yeast strains were made using
kanamycin cassette as described previously [17]. Oligonu-
cleotides used to generate the deletion cassettes are listed
in  Supplementary Table 1.
2.3. Cell culture, CSE treatment and transfection
Alveolar epithelial A549 cells were used for in vitro
experiments wherein Ham’s F12-nutrient mixture was
used  for culturing the cells. Cells were treated with dif-
ferent concentrations of CSE for different time periods as
required.  For experiments requiring excess leucine, cells
were  treated with different concentrations of leucine for
16  h prior to CSE treatment. Transient transfections were
performed using PolyFect reagent (Qiagen). To investigate
the  effect of rapamycin (Sigma Aldrich), cells were treated
with  100 nM rapamycin 2 h prior to CSE treatment and then
MTT  assay was performed after 6 h of CSE treatment.
2.4.  siRNA construct
siRNA  sequences targeted against LAT1 and MAD1 were
designed using siDESIGN software (Thermo Scientiﬁc) and
cloned  into pSuper Retro Puro vector (Oligo-Engine). The
primers  used are listed in Supplementary Table 1
2.5.  MTT assay
Cellular viability was  determined by MTT-assay as
described previously [18]. Brieﬂy A549 cells were trans-
fected with LAT1 expression construct (phLAT1) or siLAT1.
Twenty four hour post-transfection, transfectants were
either  treated or left untreated with CSE for different
periods as indicated in the ﬁgure and then MTT  assay was
performed. Similarly, in order to study the effect of excess
leucine on CSE-induced cell death, A549 cells were grown
for  16 h in presence of 0.8 mM leucine and then treated
with CSE for different time periods. After CSE treatment
MTT  assay was performed.
In  another experiment MTT  assay was  performed to
investigate the effect of mTOR inhibitor rapamycin. A549
cells  were either transfected with LAT1 construct or with
empty  vector (pcDNA3.1). After 24 h of transfection, cells
were  treated with 100 nM rapamycin for 2 h prior to 3%
CSE  treatment. After the CSE treatment for 6 h MTT  assay
was  performed.
2.6.  Real time PCR
Total  RNA from differentially treated yeast and A549
cells was extracted using TRIzol® reagent (Invitrogen). First
strand  cDNA was synthesized using 3 g of RNA from each
sample and MMLV  reverse transcriptase (Fermentas). The
synthesized cDNA was used for subsequent qPCR analysis.
The  sequences of primers used were listed in Supplemen-
tary Table 1. GAPDH was used as control for LAT1 and gene
for  actin was  used as control for yeast genes TAT1, BAP2 and
TAT2.
gy Repo754 B. Das et al. / Toxicolo
2.7. ChIP assay
A549  cells were treated with 3% CSE for 4 h and there-
after ChIP was performed [19]. The DNA-protein complex
was  immunoprecipitated using anti-Mad1 antibody (Santa
Cruz  sc:222). Nonspeciﬁc anti-rabbit IgG was used as con-
trol.  The DNA obtained was analyzed by PCR using speciﬁc
primers (Supplementary Table 1) designed to target the
E-box  at LAT1 promoter as indicated in the ﬁgure.
2.8. Exposure of guinea pigs to CS
Two to three month old male guinea pigs (250–350 g)
were  used for all the experiments. Animal care procedures
were as per NIH (National Institutes of Health) guidelines
and were approved by the Institutional Animal Ethics Com-
mittee.  Guinea pigs were fed a vitamin C-free diet for 7 days
to  minimize the vitamin C level in the plasma and tissues
as  vitamin C is a potential inhibitor of CS-induced oxida-
tive  stress [20,21]. Each animal was exposed to 3 cigarettes
per  day; 2 puffs per cigarette with 1 min  rest in smoke-
free atmosphere between each puff to allow the animals
to  breathe air. The duration of exposure was  1 min  for
each  puff. In general each puff produces 2.3 mg  suspended
particle. During the course of experiment, the guinea pigs
were  fed with either 1 mg  vitamin C/day or 1 mg  vitamin
C/day and a leucine supplement (48 mg/kg/day) for 7 days.
This  diet plan was continued for the next 14 days along
with CS exposure (three cigarettes/animal/day with two
puffs/cigarette). Control guinea pigs were not exposed to
CS.
In  a separate experiment, guinea pigs were ﬁrst exposed
to  CS for 14 days as mentioned above. Thereafter the smoke
treatment was ceased and animals were fed normal diet
along  with either vitamin C (1 mg/day) or leucine supple-
ment  (48 mg/kg/day) or both leucine and vitamin C for next
10  days. For experiments involving rapamycin treatment,
animals were fed with rapamycin (0.8 mg/kg/day) along
with  leucine (48 mg/kg/day) after an exposure to CS for 14
days.
Six  animals were used in each group for all the exper-
iments. At the end of each experiment animals were
sacriﬁced and lungs were ﬁxed by inﬂation with 10%
buffered formalin. Lung tissue sections were stained with
hematoxylin and eosin (H & E) for histological analysis.
Morphometric analysis of the lung tissue sections was
expressed by mean linear intercept (Lm) [22].
2.9. Histology and TUNEL assay
For histology, ﬁxed tissues were parafﬁn-embedded and
serially  sectioned at 5 m.  Sections were stained with H
&  E or ethidium bromide (EtBr) (4 g/ml) as per require-
ment and viewed under microscope using 10× objective
(Olympus IX71).
The  TUNEL assay was carried out on formaldehyde ﬁxed
lung  sections by ﬂuorescein-dUTP labeling using In Situ Cell
Death  Detection Kit (Roche) according to manufacturer’s
protocol. In brief, sections were deparafﬁnized with xylene
and  incubated with the labeling reagent for 30 min  at room
temperature. After the incubation, sections were washedrts 1 (2014) 752–763
with  PBS and viewed under ﬂuorescence microscope using
10×  objective. The percentages of TUNEL and EtBr posi-
tive  cells were determined using Image-Pro 6.3 software
(Media Cybernetics).
2.10.  Western blotting
Western  blotting was  performed according to standard
procedure with loading of 30 g protein for each sam-
ple. Primary antibodies were against mTOR (Cell Signaling
Technology 2983S), p-mTOR (Cell Signaling Technology
5536S), p70 S6 kinase (Santa Cruz sc-230), p-p70 S6 kinase
(Santa  Cruz sc-7984-R), Lat1 (Gene Tex GTX62591), Mad1
(Santa  Cruz sc:222) and tubulin (Santa Cruz sc-23948).
Densitometric quantiﬁcation of the western blots was done
by  ImageLab software (Bio-Rad).
2.11. Statistical analyses
Data  are represented as mean ± SD. For each experiment
six animals were used per group. Statistical signiﬁcance
between the groups was evaluated by One Way  Analysis
of  Variance (ANOVA) and Tukey’s posthoc test.
3. Results
3.1. Excess leucine in the medium protects yeast cells
against CSE-induced cell death
To investigate the connection between nutrient avail-
ability and CSE-induced stress response, we initially used
S.  cerevisiae as a model system. We  chose this system for the
following  reasons: (i) cellular response pathways to many
stress  factors are known to be conserved between yeast
and  mammalian cells; (ii) yeast cells grow faster and thus
use  of this system expedites the screening process; and (iii)
while  culture of mammalian cells needs serum, a complex
media component, yeast cells can be grown in synthetic
media where the precise composition allows manipulation
of media components. The last factor is especially impor-
tant  in the context of the present study, which is dependent
upon modulation of nutrient composition. The fact that
yeast  cells are known to respond to CSE [23] and are more
amenable to genetic analyses compared to cultured mam-
malian  cells provides additional justiﬁcation of using this
system.  We  have standardized the dose and duration of
CSE  treatment sufﬁcient to cause lethality of yeast cells.
The  minimum concentration of CSE that could completely
inhibit cell growth was  20% and required an exposure
time of 4 h (Supplementary Fig. 1). Hence all subsequent
experiments with yeast were performed using this condi-
tion.  To determine if nutrient availability could rescue the
growth  defect caused by CSE treatment, cells were grown
in  medium containing two-fold excess of either glucose or
amino  acids. While both nutrients protected cells against
CSE-induced death, cells grown in excess amino acids were
better  protected compared to those grown in excess glu-
cose  (Fig. 1A). Next we examined the effect of individual
amino acids and observed that only two branched chain
amino acids, leucine and isoleucine, were able to protect
cells  from CSE-induced death with leucine being more
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Fig. 1. Excess nutrients prevent CS-induced cell death in S. cerevisiae. (A) Effects of excess glucose and amino acid mixture. Exponentially growing cells
in  YCM or YCM supplemented with either 2× glucose or 2× amino acids, were treated or left untreated with 20% (V/V) CSE for 4 h. Serial dilutions were
spotted  on YCM plates, following which the plates were incubated at 30 ◦C for the indicated time periods (48 or 72 h) before scoring for growth. (B) Effects
of  individual amino acids. Exponentially growing cells in YCM supplemented with 2× concentration of each of the indicated amino acids, were treated
as  in (a) above. The YCM plates were incubated at 30 ◦C for 72 h. V: valine; L: leucine; I: isoleucine; S: serine; K: lysine; Y: tyrosine; W:  tryptophan; T:
threonine;  F: phenylalanine; H: histidine; M:  methionine; R: argnine; N: asparagine; E: glutamic acid. (C) Effects of overexpressing TAT1 and BAP2. S.
cerevisiae  transformants overexpressing either TAT1 or BAP2 from YEp24 vector were treated with 20% CSE as indicated, serially diluted and spotted on
YCM  plates lacking uracil. Plates were incubated at 30 ◦C for 72 h. Empty vector (YEp24) transformants were used as control in the experiment. (D) bap2
is  more sensitive to CSE-treatment. Wild-type, tat1 and bap2 cells were treated with indicated concentrations of CSE for 4 h, spotted on YCM plates and
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ur  assay conditions.
As  excess leucine and isoleucine protected cells from
SE-induced death, it is possible that over-expression
f the transporters of these amino acids will have a
imilar effect. To test this, BAP2 and TAT1, genes encod-
ng  two branched chain amino acid transporters [24,25]
ere  expressed from a multicopy vector (YEp24). Whileast cells, and LAT1 in A549 cells. S. cerevisiae and A549 cells were either
ure) with 20% CSE for yeast and 3% CSE for A549. Expression of BAP2 and
t mean ± SD of data from three independent experiments; *P < 0.05.
overexpression of both transporters conferred resistance
to  20% CSE exposure for 2 h, only BAP2 overexpressing cells
were  able to grow following CSE treatment for 4 h (Fig. 1C).
Correspondingly, bap2 cells displayed increased sensitiv-
ity  to CSE compared to wild-type cells, whereas sensitivity
of  tat1 cells was  comparable to that of wild-type (Fig. 1D).
Since  both excess leucine in the medium and overex-
pression of BAP2 rescued CSE-induced growth inhibition
of  yeast cells, it is possible that CSE exposure results in
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downregulation of the leucine transporters. Therefore, we
examined  the level of BAP2 and TAT1 expression in CSE-
treated yeast cells and observed a signiﬁcant reduction in
expression  of both genes relative to that of untreated cells
(Fig.  1E). Since CSE exposure results in death of alveolar
epithelial A549 cells [26,27], we examined the expression
of  LAT1 that encodes a transporter for neutral branched
chain amino acids like leucine and isoleucine [12,28] in
A549  cells following CSE treatment. Consistent with the
results  of the studies in yeast, we observed a signiﬁcant
reduction in LAT1 expression level compared to control
cells  (Fig. 1E). Thus CSE exposure causes downregulation
of amino acid transporter(s) of leucine and isoleucine in
both  mammalian and yeast cells.
3.2. LAT1 overexpression and excess leucine make A549
cells  less sensitive to CSE
Since  CSE exposure downregulates LAT1 in A549 cells,
we  examined if the overexpression of LAT1 prevents CSE-
induced  cell death. We  transfected A549 cells with either a
construct  that constitutively expresses LAT1 or the empty
vector  (pcDNA3.1). The transfectants were treated with CSE
and  cell viability was determined by MTT  assay. It was
observed that cells transfected with the LAT1 construct dis-
played  signiﬁcantly enhanced viability compared to control
transfectants (Fig. 2A). This result indicates that overex-
pression of LAT1 in A549 cells protected the cells from
CSE-induced death. Correspondingly, we veriﬁed the effect
of  extra leucine in the media. Cells were grown in presence
of  extra leucine ranging from 0.4 mM to 1.6 mM and treated
with  3% CSE for 6 h. Consistent with our expectation, addi-
tion  of extra leucine to the media resulted in better survival
of  A549 cells following treatment with CSE wherein 0.8 mM
leucine  exhibited best result (Supplementary Fig. 2). Time
kinetics  of cell survival with 0.8 mM leucine was per-
formed. The result again demonstrated a protective role
of  leucine against CSE-induced death (Fig. 2B). However,
leucine was found to be less effective than LAT1 (compare
Fig. 2A and B). Cell viability was also conﬁrmed by trypan
blue  dye exclusion assay, which yielded results consistent
with those for the MTT  assays (Supplementary Fig. 3A and
B).  In agreement with the results obtained in yeast, excess
methionine in the medium failed to provide such protec-
tion  (Supplementary Fig. 4). To further conﬁrm the role of
LAT1,  we investigated if downregulation of LAT1 made cells
more  sensitive to CSE. A549 cells were transfected with
a  construct expressing a siRNA targeted to LAT1. Consis-
tent  with our hypothesis, both MTT  and trypan blue assay
showed  that si-LAT1 transfectants exhibited reduced cell
viability  compared to control cells (Fig. 2C, Supplementary
Fig. 3C).
3.3.  LAT1 and leucine-mediated protection against CSE
involves mTOR activation
Both  excess leucine and overexpression of LAT1 are
known to cause activation of mTOR [29–32]. Thus, leucine
or  Lat1-mediated cellular protection against CSE may  be
exerted  through mTOR activation. Upon activation, mTOR
becomes phosphorylated and in turn phosphorylates itsrts 1 (2014) 752–763
effector  p70S6 kinase [13]. Thus, to assess the status
of mTOR activation in CSE-treated LAT1 transfectants,
we monitored the phosphorylation status of mTOR and
p70S6  kinase by western blotting. While mTOR and p70S6
kinase  levels remained constant, a signiﬁcant reduction
was  observed in their phosphorylated forms after CSE
treatment (Fig. 3A). However, over expression of LAT1
prevented this reduction (Fig. 3A). Taken together these
results suggest that mTOR is deactivated upon CSE treat-
ment  and elevated levels of Lat1 prevents this deactivation.
Prevention of mTOR deactivation was also observed in
cells  treated with excess leucine (Supplementary Fig. 5A).
To  conﬁrm the involvement of mTOR in both Lat1 and
leucine mediated prevention of CSE-induced cell death,
mTOR  inhibitor rapamycin was added to A549 cells 2 h
prior  to CSE treatment and both cell survival and p70S6
kinase phosphorylation were examined. Cell survival and
p70S6  kinase phosphorylation were signiﬁcantly reduced
upon  rapamycin treatment in both LAT1 transfectants and
cells  grown in the presence of excess leucine (Fig. 3B and
Supplementary Fig. 5B). Thus LAT1 downregulation is the
key  cellular event that leads to mTOR deactivation in CSE-
treated  cells.
To  understand the mechanism of CS-induced LAT1
downregulation, we examined the upstream promoter
elements of LAT1 and identiﬁed an E-box, a known bind-
ing  site for Mad  family of transcription repressors [33].
Therefore, we  investigated if Mad1 level is altered upon
CSE-treatment. We  observed an elevated level of Mad1 in
CSE-treated cells compared to control cells (Fig. 3C). Con-
sistent  with our hypothesis that Mad1 negatively regulates
LAT1,  the level of Lat1 was  found to be inversely pro-
portional to Mad1 level in these cells (Fig. 3C). To verify
Mad1’s involvement in CSE-induced LAT1 downregulat-
ion, we examined Lat1 level in A549 cells, wherein MAD1
expression was downregulated by si-MAD1 prior to CSE
treatment. Western blot analysis showed higher levels of
Lat1  in CSE-treated si-MAD1 transfectants compared to
CSE-treated control transfectants (Fig. 3C). Results of MTT
assay  also showed that these si-MAD1 transfectants were
more  resistant to CSE-induced cell death (Fig. 3D). These
results indicate that exposure to CSE results in Mad1-
mediated repression of LAT1. To conﬁrm that Mad1 binds
to  the promoter of LAT1, we performed ChIP analysis using
anti-Mad1 antibody. The result showed that Mad1 binds to
the  LAT1 promoter element when cells were treated with
CSE  (Fig. 3E).
3.4.  Leucine supplement in diet imparts resistance to
CS-induced lung tissue damage
Given that either addition of extra leucine to the growth
medium, or overexpression of the high-afﬁnity transporter
for  leucine, provide protection against CSE-induced cell
death  in both S. cerevisiae and A549 cells, we deter-
mined if leucine supplement has the ability to impart
similar resistance in vivo. We  conducted our studies in
guinea  pig model. Guinea pigs were kept on vitamin C-free
diet  for 7 days and then administered leucine supple-
ment in diet for another 7 days followed by CS exposure
for 14 days, during which the excess leucine diet was
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Fig. 2. Ectopic expression of LAT1 and excess leucine protected A549 cells from CSE-induced cell death. (A) A549 cells transfected with LAT1 expression
construct  exhibit less sensitivity to CSE. A549 cells were transfected either with a construct that expresses LAT1 from viral promoter or with the empty
vector  (pcDNA3.1). Twenty four hour post-transfection, transfectants were either treated with 3% CSE, or left untreated for different periods as indicated.
Cell  viability was  assessed by MTT  assay. (B) Excess leucine in the growth medium partially rescues A549 cells from CSE-induced cell death. A549 cells
were  grown for 16 h in presence or absence of 0.8 mM leucine. Cells were then treated with 3% CSE for different time periods as indicated and cell viability
was  assayed by MTT assay. (C) Downregulation of LAT1 makes A549 cells more sensitive to CSE. A549 cells were transfected either with si-LAT1 or pSUPER
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ith H & E. We  observed that while tissue sections of con-
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amage following CS exposure, the extent of such dam-
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eucine-supplement (Fig. 4A and B). Consistent with the
esults  obtained in A549 cells, western blot analysis of lung
issue  homogenates showed that exposure to CS resulted
n  signiﬁcant reduction in the levels of phospho-mTOR and
hospho-p70S6 kinase (Fig. 4C). In contrast, this reduction
as  attenuated in animals receiving leucine-supplement
Fig. 4C). Additionally, we also observed signiﬁcant reduc-
ion  of Lat1 level in the lung extract of CS-exposed guinea
ig  compared to lung extract from guinea pig that was
ot  exposed to CS. Similar to A549 cells, this reduction
as found to be inversely related with Mad1 expression
Fig. 4C). Collectively, these results from guinea pigs vali-
ate  all the in vitro results obtained from A549 cells.
.5.  Leucine administration ameliorates pre-existing
mphysematous changes in lung tissue
There are no reports of any therapeutic agent capa-
le of reversing pre-existing emphysematous condition
f  lung. Since leucine administration prevents CS-induced
ung damage through mTOR activation, we tested if leucine
dministration is able to reverse pre-existing CS-induced
onditions in lung. First guinea pigs were exposed to CS forE for 4 h and cell viability was assayed by MTT  assay. Western blotting,
vels of Lat1. Densitometric quantiﬁcation for Lat1 was normalized against
ndent experiments;*P < 0.05, **P < 0.005.
14  days and thereafter administered leucine for 10 days
during which animals were not exposed to CS. Control
animals were either left untreated or treated with vita-
min  C, which is known to prevent CS-induced emphysema
[21]. The lung sections of leucine-treated animals displayed
considerably less pulmonary damage compared to animals
exposed to CS (Fig. 5A, compare panels 2 and 3 with panel
5;  Fig. 5B). As expected, vitamin C was  unable to cause any
signiﬁcant reversal of lung tissue damage (Fig. 5A, com-
pare  panels 2 and 3 with panel 4; Fig. 5B). Thus these
results indicate that leucine is able to reverse even exist-
ing  emphysematous condition of lung and this reversal
may  involve mTOR activity as signiﬁcantly increased p70S6
kinase  phosphorylation was  observed in lung extracts
obtained from leucine treated guinea pig compared to
untreated (Fig. 5C).
To  conﬁrm the involvement of mTOR in leucine-
mediated reversal of CS-induced lung damage, animals
were fed with rapamycin along with leucine for 10 days
following 14 days of exposure to CS. Administration of
rapamycin, along with leucine, resulted in considerable
reduction in the reversal of lung tissue damage compared
to  the tissue damage reversal observed in animals that
were  fed with leucine alone following exposure to CS
(Fig.  6A and B, compare panels 3 and 4). Consistent with
the  histology pattern, western blot analysis also showed
a  signiﬁcant reduction of phosho-p70S6 kinase level in
rapamycin and leucine treated lung tissue extract com-
pared to the corresponding leucine treated extract (Fig. 6C,
lanes  3 and 4). Taken together these results demonstrated
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Fig. 3. Downregulation of LAT1 by CSE causes mTOR inactivation and involves Mad1. (A) Ectopic expression of LAT1 in A549 cells prevents CSE-induced
mTOR  inactivation. A549 cells were transfected with either a construct expressing LAT1 or empty vector (pcDNA3.1). Twenty four hour post-transfection,
transfectants were either treated with CSE for 4 h or left untreated. Western blotting and densitometric quantiﬁcation of different proteins were performed
(data  normalized against tubulin). Results represent mean ± SD of data obtained from three independent experiments; *P < 0.05. (B) Rapamycin counters
LAT1-mediated  cell survival. A549 transfectants were treated with rapamycin for 2 h prior to CSE-treatment for 6 h. Cell viability was examined by MTT
assay  and phospho-p70S6 kinase level was  examined. Data represented as mean ± SD from three independent experiments; *P < 0.05. (C) Lat1 level is
regulated  by Mad1. A549 cells were transfected with either si-MAD1 or empty vector. Twenty four hour post-transfection, transfectants were either
treated  with CSE for 4 h or left untreated. Western blotting and densitometric quantiﬁcation for Lat1 and Mad1 were performed (data normalized against
tubulin).  Results represent mean ± SD of data obtained from three independent experiments; *P < 0.05. (D) MAD1 downregulation provides protection
against  CSE. A549 cells were transfected with either si-MAD1 or empty vector. Twenty four hour post-transfection, transfectants were either treated with
3%  CSE for 8 h or left untreated. Cell viability was  assessed by MTT  assay. Results represent mean ± SD of data obtained from three independent experiments;
*P  < 0.05. (E) ChIP analysis. CSE-treated A549 cells were cross-linked with paraformaldehyde. Chromatin was  immunoprecipitated with anti-Mad1 antibody.
 to the EImmunoprecipitated  DNA was  ampliﬁed with PCR primers corresponding
upper  panel and analyzed by agarose gel electrophoresis.
that leucine mediated amelioration of pre-existing emphy-
sematous changes in lung tissue was mediated through
mTOR activation.
Given  that lung tissue damage in CS-exposed animals
results from cellular death, we stained lung tissue sections
with  EtBr to determine if administration of excess leucine
in  the diet alters the extent of cellular death. Extensive cel-
lular  death was observed in lung sections of CS-exposed
animals compared to the control animals (Fig. 7A, compare-Box binding site at LAT1 upstream promoter sequence as indicted in the
panels  1 and 2). However, this CS-induced cellular death
was  reduced in lung sections from animals that were fed
with  leucine for 10 days after an exposure to CS for 14 days
(Fig.  7A, compare panels 2 and 3). Since this CS-induced
cellular death is attributed, at least in part, to apoptosis
(4), we  examined the level of apoptosis in the lung sec-
tions  by TUNEL assay. Consistent with the results of EtBr
staining, we observed considerable reduction of TUNEL-
positive apoptoic cells in lung sections of leucine treated
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Fig. 4. Leucine supplement in diet prevents CS-induced lung tissue damage in guinea pig by activating mTOR. (A) Leucine-supplemented diet prevents
lung  tissue damage by CS. Guinea pigs were administered leucine-supplemented diet for 7 days followed by CS exposure for 14 days during which leucine
supplement  was maintained. Fixed lung sections were stained with H & E and viewed under microscope (n = 6 animals in each group). Scale bars: 300 m. (B)
Morphometric  analysis. Morphometric analysis was performed and expressed by mean linear intercept (Lm) of lung tissue sections obtained from animals
in  panel A (18 ﬁelds for each group). Data are represented as mean ± SD; *P < 0.05. (C) Leucine counters mTOR inactivation in the lung of CS-exposed guinea
p y weste
s nimals 
s D; *P < 0
a
n
r
d
o
4
p
T
m
l
i
u
t
a
r
f
c
m
tig.  Lung tissue homogenates from animals of panel A were analyzed b
ix  independent experiments from the lung tissue homogenate of three a
hown  was  normalized against tubulin. Data are represented as mean ± S
nimals compared to animals that were exposed to CS but
ot  treated with leucine (Fig. 7B). Taken together the above
esults  indicate that leucine can reverse the pulmonary
amage caused by exposure to CS through the activation
f  mTOR pathway.
.  Discussion
The current study demonstrates that leucine sup-
lement can attenuate cellular damage caused by CS.
he  study was initiated in the genetically facile yeast
odel wherein nutritional supplement, particularly excess
eucine  in growth media, made cells resistant to CSE-
nduced cell death. Similar resistance was also conferred
pon overexpression of the branched chain amino acid
ransporter Bap2 (Fig. 1C). Cells overexpressing Tat1,
nother branched chain amino acid transporter, were less
esistant  compared to those overexpressing Bap2. This dif-
erence  is likely due to the higher afﬁnity of Bap2 for leucine
ompared to Tat1 [34]. Consistently while bap2 cells were
ore  sensitive to CSE-induced growth inhibition compared
o  wild-type, tat1 cells exhibited sensitivity similar torn blotting for different proteins. The blots shown are representative of
in each group. Densitometric quantiﬁcation was  performed and the data
.05.
wild-type  levels. This is most likely because tat1 cells
contain functional Bap2.
Overexpression of the mammalian transporter for
leucine, LAT1, as well as excess leucine in the growth
medium, protected A549 lung epithelial cells against CSE-
induced  cell death. This protection stems from the ability
of  leucine to activate mTOR [29]. There is a positive correla-
tion  between mTOR activation and mitochondrial function
as  increased mitochondrial activity leads to the downreg-
ulation of AMPK, a negative regulator of mTOR signaling
complex [35]. Leucine can enhance mitochondrial func-
tions  in two ways: (i) by serving as a mitochondrial fuel
upon  undergoing oxidative decarboxylation and (ii) by act-
ing  as an allosteric activator of glutamate dehydrogenase
that produces  ketogluterate, a TCA cycle intermediate
[30].
Although leucine pre-treatment provides protection
against CS-induced cell death, this protection is only par-
tial.  This is likely because CS has pleiotropic effects on
multiple cellular pathways. For example, CS exposure
has been shown to cause protein degradation, inhibit
protein synthesis, and induce both DNA damage and
oxidative stress [20,36]. Elevated leucine level most likely
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Fig. 5. Dietary leucine supplement reverses pre-existing emphysematous changes in lung tissue. (A) Histology of differentially treated animals. Guinea pigs
were  differentially treated as follow: (1) Control animals not exposed to CS. (2) Animals exposed to CS for 14 days and sacriﬁced. (3) Animals exposed to
CS  for 14 days and then left untreated for another 10 days before sacriﬁce. (4) Animals exposed to CS for 14 days and then fed vitamin C supplemented diet
for  10 days before sacriﬁce. (5) Animals exposed to CS for 14 days and then fed leucine supplemented diet for 10 days before sacriﬁce. Fixed lung sections
from  these animals were stained with H & E and viewed under microscope. Scale bars: 300 m.  (n = 6 animals in each group). (B) Morphometric analysis.
Morphometric analysis of lung tissue sections obtained from differentially treated animals (18 ﬁelds for each group) was performed and expressed by mean
linear  intercept (Lm). Data are represented as mean ± SD; *P < 0.05. (C) Leucine treatment induces p70S6 kinase phosophorylation in the lung of CS-exposed
guinea  pig. Lung tissue homogenates from differentially treated guinea pigs were analyzed by western blotting. Lane1: Control; Lane2: CS treatment (14
t (10 da
ed and tdays)  only; Lane3: CS treatment (14 days) followed by leucine treatmen
(n  = 3 animals in each group). Densitometric quantiﬁcation was  perform
mean  ± SD; *P < 0.05.
counteracts only a subset of these pathophysiological
effects related to protein synthesis. Consistently, we
observed that although leucine could reverse the ROS-
mediated downregulation of mTOR, it could not reduce ROS
generation  (Supplementary Fig. 6). Another reason why
leucine  can only partially rescue the effects of CS is because
CS  causes downregulation of the amino acid transporter
Lat1, the primary mode of entry of leucine into the cell.
Besides leucine, Lat1 also transports other neutral essen-
tial  amino acids such as isoleucine, valine and aromatic
amino acids like phenylalanine, tryptophan and tyrosine
[12].  Thus downregulation of LAT1 leads to a deﬁciency of
multiple  amino acids and leucine alone is unlikely to be a
remedy  for such a deprivation of multiple nutrients. Consis-
tently,  we observed that ectopic expression of LAT1 is more
efﬁcient  in combating CS-induced cell death compared toys). The blots shown are representative of six independent experiments
he data shown was  normalized against tubulin. Data are represented as
administration of excess leucine (Fig. 2A). In addition, our
results  in S. cerevisiae showed that besides BAP2, other
amino acid permeases like TAT1 (Fig. 1E) and TAT2 are also
downregulated by CSE (Supplementary Fig. 7) indicating
that this xenobiotic mixture is likely to cause downregu-
lation of multiple nutrient transporters. Such a repression
of  the multiple nutrient transporters may  also be taking
place in human cells because the E-box element, the bind-
ing  site of Mad1 repressor, is also present in the promoter
elements of several human amino acid transporters.
Previous studies reported a reduction in protein syn-
thesis upon exposure to CS but the underlying mechanism
has remained unclear [20,37]. One potential mechanism
revealed by Yoshida et al. involved inactivation of mTOR
[38].  This inactivation is mediated by a stress-related pro-
tein  Rtp801 that activates TSC2, a negative regulator of
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Fig. 6. Rapamycin treatment inhibits the ability of dietary leucine to reverse pre-existing emphysematous changes. (A) Histology of differentially treated
animals.  Guinea pigs were differentially treated as follows: (1) Control animals. (2) Animals exposed to CS for 14 days and then left untreated for another
10  days before sacriﬁce. (3) Animals exposed to CS for 14 days and then fed with leucine for 10 days before sacriﬁce. (4) Animals exposed to CS for 14 days
and  then fed with leucine and rapamycin for 10 days before sacriﬁce. Fixed lung sections from these animals were stained with H & E and viewed under
microscope.  Scale bars: 300 m.  (n = 6 animals in each group). (B) Morphometric analysis. Morphometric analysis of lung tissue sections obtained from
differentially  treated animals (18 ﬁelds for each group) was  performed and expressed by mean linear intercept (Lm). Data are represented as mean ± SD;
*P  < 0.05. (C) Rapamycin inhibits leucine-induced phosphorylation of p70S6 kinase in CS-exposed guinea pig lung. Tissue homogenates, prepared from
lungs  of animals in panel A, were analyzed by western blotting. The blots shown are representative of six independent experiments (n = 6 animals per
group).  Densitometric quantiﬁcation was performed and the data shown was normalized against tubulin. Data are represented as mean ± SD; *P < 0.05.
Fig. 7. Effect of leucine supplemented diet on cellular death proﬁle of animals with emphysema. Guinea pigs were treated as follows: (1) Control animals.
(2)  Animals exposed to CS for 14 days and then left untreated for another 10 days before sacriﬁce. (3) Animals exposed to CS for 14 days and then fed
leucine  supplemented diet for 10 days before sacriﬁce. Six animals were used for each group. Fixed lung sections from these animals were stained with
EtBr  to examine cellular death. (A) Sections were also subjected to TUNEL assay for detection of apoptosis (B) The percentage of EtBr and TUNEL positive
cells  were determined (18 ﬁelds for each group). Data are represented as mean ± SD; *P < 0.05.
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mTOR. The current study uncovers an additional mech-
anism of mTOR inactivation by CS wherein CS causes
downregulation of amino acid transporter Lat1.
Previous reports have documented the induction of
autophagy following exposure to CS [7,8]. However, the
underlying mechanism by which CS induces autophagy is
not  well understood. Our results showing that exposure
to  CS results in downregulation of amino acid trans-
porter(s) provides a possible link between CS exposure
and autophagy wherein reduced nutrient availability may
trigger  a starvation-induced autophagic response. Future
investigations are necessary to conﬁrm this hypothesis.
The effect of leucine on CS-induced cell death was also
validated in the guinea pig. Guinea pig is a good ani-
mal  model system to study CS-induced damage as, like
humans, this animal is unable to synthesize vitamin C, a
known  antioxidant. Thus dietary supplementation is the
only  source of this important vitamin. Since CS-induced
oxidative stress is crucial in developing emphysema, pre-
vious  studies have shown that restricting the availability
of vitamin C in the diet results in accelerated emphysema-
tous changes [15,21]. Using this same strategy of vitamin
C  deprivation, we have been able to establish accelerated
development of CS-induced atherosclerosis in guinea pig
aorta  [39].
Using this model, the current study identiﬁes a likely
treatment option for emphysema, a disease hitherto
thought to be irreversible. Previous reports document that
the  onset of emphysema may  be prevented with antiox-
idants such as black tea and vitamin C [15,21]. However,
until now, no cure has been reported. Lung transplant is the
only  option, but this is hardly a cure because of organ donor
scarcity, the prohibitive cost of the procedure and the poor
health  of most emphysema patients. The current study is
the  ﬁrst to document a non-surgical therapeutic option for
this  condition as leucine is able to reverse even pre-existing
emphysematous changes in CS-exposed guinea pig lung.
Leucine  therapy is likely to have minimal side effects as
it  has already been used as a therapeutic agent for skele-
tal  muscle atrophy, Diamond-Blackfan anemia and obesity
[40–42].
5.  Conclusion
The current study documents a new mechanism by
which CS affects cellular physiology wherein amino acid
transporters are a key target and that leucine is likely to
have  signiﬁcant therapeutic potential for treating emphy-
sema  resulting from CS exposure.
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